| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | EPHB3 OR10D3 OR12D3 OR2K2 ANTXRL ITGA11 OR2A7 OR13D1 EFEMP1 TRHR PTPRK OR10G2 LPAR6 OR2A4 OR13F1 PECAM1 OR4D1 OR5C1 NMUR1 OR6Y1 OR6K3 OR8K3 OR8U3 GRIN2C ADGRV1 OR2Z1 OR51B4 GPR45 | 9.18e-14 | 1353 | 79 | 28 | GO:0004888 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR10D3 OR12D3 OR2K2 OR2A7 OR13D1 OR10G2 OR2A4 OR13F1 OR4D1 OR5C1 OR6Y1 OR6K3 OR8K3 OR8U3 OR2Z1 OR51B4 | 1.05e-11 | 431 | 79 | 16 | GO:0004984 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR10D3 OR12D3 OR2K2 OR2A7 OR13D1 TRHR OR10G2 LPAR6 OR2A4 OR13F1 OR4D1 OR5C1 NMUR1 OR6Y1 OR6K3 OR8K3 OR8U3 ADGRV1 OR2Z1 OR51B4 GPR45 | 1.91e-11 | 884 | 79 | 21 | GO:0004930 |
| GeneOntologyMolecularFunction | odorant binding | 7.07e-07 | 127 | 79 | 7 | GO:0005549 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR10D3 OR12D3 OR2K2 OR2A7 OR13D1 OR10G2 OR2A4 OR13F1 OR4D1 OR5C1 OR6Y1 OR6K3 OR8K3 OR8U3 OR2Z1 OR51B4 | 8.23e-12 | 432 | 80 | 16 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR10D3 OR12D3 OR2K2 OR2A7 OR13D1 OR10G2 OR2A4 OR13F1 OR4D1 OR5C1 OR6Y1 OR6K3 OR8K3 OR8U3 OR2Z1 OR51B4 | 2.47e-11 | 465 | 80 | 16 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR10D3 OR12D3 OR2K2 OR2A7 OR13D1 OR10G2 OR2A4 OR13F1 OR4D1 OR5C1 OR6Y1 OR6K3 OR8K3 OR8U3 OR2Z1 OR51B4 | 4.62e-11 | 485 | 80 | 16 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR10D3 OR12D3 OR2K2 OR2A7 OR13D1 OR10G2 OR2A4 OR13F1 OR4D1 OR5C1 OR6Y1 OR6K3 OR8K3 OR8U3 ADGRV1 OR2Z1 OR51B4 | 7.06e-11 | 582 | 80 | 17 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR10D3 OR12D3 OR2K2 OR2A7 OR13D1 OR10G2 OR2A4 OR13F1 OR4D1 OR5C1 OR6Y1 OR6K3 OR8K3 OR8U3 OR2Z1 OR51B4 | 1.45e-10 | 524 | 80 | 16 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR10D3 OR12D3 OR2K2 OR2A7 OR13D1 OR10G2 OR2A4 OR13F1 OR4D1 OR5C1 OR6Y1 OR6K3 OR8K3 OR8U3 OR2Z1 OR51B4 | 2.71e-10 | 547 | 80 | 16 | GO:0007606 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR10D3 OR12D3 OR2K2 OR2A7 PDE4B OR13D1 TRHR OR10G2 LPAR6 OR2A4 OR13F1 OR4D1 OR5C1 NMUR1 OR6Y1 OR6K3 OR8K3 OR8U3 ADGRV1 OR2Z1 PDE10A OR51B4 GPR45 | 1.68e-09 | 1395 | 80 | 23 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR10D3 OR12D3 OR2K2 OR2A7 OR13D1 OR10G2 OR2A4 OR13F1 OR4D1 OR5C1 OR6Y1 OR6K3 OR8K3 OR8U3 ADGRV1 OR2Z1 OR51B4 | 1.91e-09 | 722 | 80 | 17 | GO:0051606 |
| GeneOntologyBiologicalProcess | sensory perception | OR10D3 OR12D3 OR2K2 OR2A7 OR13D1 EFEMP1 OR10G2 OR2A4 OR13F1 OR4D1 OR5C1 OR6Y1 OR6K3 OR8K3 OR8U3 ADGRV1 OR2Z1 OR51B4 | 1.10e-07 | 1072 | 80 | 18 | GO:0007600 |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 5.04e-05 | 169 | 80 | 6 | GO:0010977 | |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 2.92e-04 | 233 | 80 | 6 | GO:0031345 | |
| GeneOntologyBiologicalProcess | negative regulation of interferon-alpha production | 3.08e-04 | 7 | 80 | 2 | GO:0032687 | |
| Domain | GPCR_Rhodpsn_7TM | OR12D3 OR2K2 OR2A7 OR13D1 TRHR OR10G2 LPAR6 OR2A4 OR13F1 OR4D1 OR5C1 NMUR1 OR6Y1 OR6K3 OR8K3 OR8U3 OR2Z1 OR51B4 GPR45 | 4.03e-11 | 670 | 80 | 19 | IPR017452 |
| Domain | 7tm_1 | OR12D3 OR2K2 OR2A7 OR13D1 TRHR OR10G2 LPAR6 OR2A4 OR13F1 OR4D1 OR5C1 NMUR1 OR6Y1 OR6K3 OR8K3 OR8U3 OR2Z1 OR51B4 GPR45 | 4.81e-11 | 677 | 80 | 19 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR12D3 OR2K2 OR2A7 OR13D1 TRHR OR10G2 LPAR6 OR2A4 OR13F1 OR4D1 OR5C1 NMUR1 OR6Y1 OR6K3 OR8K3 OR8U3 OR2Z1 OR51B4 GPR45 | 5.88e-11 | 685 | 80 | 19 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR12D3 OR2K2 OR2A7 OR13D1 TRHR OR10G2 LPAR6 OR2A4 OR13F1 OR4D1 OR5C1 NMUR1 OR6Y1 OR6K3 OR8K3 OR8U3 OR2Z1 OR51B4 GPR45 | 6.82e-11 | 691 | 80 | 19 | PS50262 |
| Domain | GPCR_Rhodpsn | OR12D3 OR2K2 OR2A7 OR13D1 TRHR OR10G2 LPAR6 OR2A4 OR13F1 OR4D1 OR5C1 NMUR1 OR6Y1 OR6K3 OR8K3 OR8U3 OR2Z1 OR51B4 GPR45 | 6.99e-11 | 692 | 80 | 19 | IPR000276 |
| Domain | Olfact_rcpt | OR12D3 OR2K2 OR2A7 OR13D1 OR10G2 OR2A4 OR13F1 OR4D1 OR5C1 OR6Y1 OR6K3 OR8K3 OR8U3 OR2Z1 OR51B4 | 1.03e-10 | 393 | 80 | 15 | IPR000725 |
| Domain | - | 5.42e-05 | 3 | 80 | 2 | 3.30.70.590 | |
| Domain | PAP_central | 5.42e-05 | 3 | 80 | 2 | PF04928 | |
| Domain | PAP_RNA-bind | 5.42e-05 | 3 | 80 | 2 | PF04926 | |
| Domain | PolA_pol_cen_dom | 5.42e-05 | 3 | 80 | 2 | IPR007012 | |
| Domain | PolA_pol_RNA-bd_dom | 5.42e-05 | 3 | 80 | 2 | IPR007010 | |
| Domain | PolyA_polymerase | 5.42e-05 | 3 | 80 | 2 | IPR014492 | |
| Domain | NuclTrfase_I_C | 5.42e-05 | 3 | 80 | 2 | IPR011068 | |
| Domain | PTPc | 4.88e-04 | 36 | 80 | 3 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 6.19e-04 | 39 | 80 | 3 | PS50055 | |
| Domain | Galactose-bd-like | 7.10e-04 | 94 | 80 | 4 | IPR008979 | |
| Domain | PTPase_domain | 7.17e-04 | 41 | 80 | 3 | IPR000242 | |
| Domain | Y_phosphatase | 7.17e-04 | 41 | 80 | 3 | PF00102 | |
| Domain | NTP_transf_2 | 9.72e-04 | 11 | 80 | 2 | PF01909 | |
| Domain | Polymerase_NTP_transf_dom | 9.72e-04 | 11 | 80 | 2 | IPR002934 | |
| Domain | PTPc_motif | 2.07e-03 | 59 | 80 | 3 | SM00404 | |
| Domain | Tyr_Pase_cat | 2.07e-03 | 59 | 80 | 3 | IPR003595 | |
| Domain | PDEase | 2.96e-03 | 19 | 80 | 2 | IPR023088 | |
| Domain | PDEase_I | 3.61e-03 | 21 | 80 | 2 | PF00233 | |
| Domain | PDEASE_I | 3.61e-03 | 21 | 80 | 2 | PS00126 | |
| Domain | PDEase_CS | 3.61e-03 | 21 | 80 | 2 | IPR023174 | |
| Domain | - | 3.79e-03 | 73 | 80 | 3 | 2.60.120.260 | |
| Domain | Tyr_Pase_AS | 3.79e-03 | 73 | 80 | 3 | IPR016130 | |
| Domain | - | 3.96e-03 | 22 | 80 | 2 | 1.10.1300.10 | |
| Domain | NACHT | 4.32e-03 | 23 | 80 | 2 | PS50837 | |
| Domain | NACHT_NTPase | 4.32e-03 | 23 | 80 | 2 | IPR007111 | |
| Domain | PDEase_catalytic_dom | 4.32e-03 | 23 | 80 | 2 | IPR002073 | |
| Domain | HDc | 4.70e-03 | 24 | 80 | 2 | SM00471 | |
| Domain | HD/PDEase_dom | 4.70e-03 | 24 | 80 | 2 | IPR003607 | |
| Domain | fn3 | 5.17e-03 | 162 | 80 | 4 | PF00041 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR10D3 OR12D3 OR2K2 OR2A7 OR13D1 OR10G2 OR2A4 OR13F1 OR4D1 OR5C1 OR6Y1 OR6K3 OR8K3 OR8U3 OR2Z1 OR51B4 | 3.44e-11 | 417 | 64 | 16 | M4072 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR12D3 OR2K2 OR2A7 OR13D1 OR10G2 OR2A4 OR13F1 OR4D1 OR5C1 OR6Y1 OR6K3 OR8K3 OR8U3 OR2Z1 OR51B4 | 1.46e-10 | 389 | 64 | 15 | M14091 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR10D3 OR12D3 OR2K2 OR2A7 OR13D1 OR10G2 OR2A4 OR13F1 OR4D1 OR5C1 OR6Y1 OR6K3 OR8K3 OR8U3 OR2Z1 OR51B4 | 1.58e-08 | 636 | 64 | 16 | M41834 |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR10D3 OR12D3 OR2K2 OR2A7 OR13D1 OR10G2 OR2A4 OR13F1 OR4D1 OR5C1 OR6Y1 OR6K3 OR8K3 OR8U3 OR2Z1 OR51B4 | 1.14e-16 | 340 | 82 | 16 | 11875048 |
| Pubmed | OR10D3 OR12D3 OR2K2 OR2A7 OR13D1 OR10G2 OR2A4 OR13F1 OR4D1 OR5C1 OR6Y1 OR6K3 OR8K3 OR8U3 OR2Z1 OR51B4 | 1.14e-16 | 340 | 82 | 16 | 11802173 | |
| Pubmed | OR10D3 OR12D3 OR2K2 OR2A7 OR13D1 OR10G2 OR2A4 OR13F1 OR4D1 OR5C1 OR6Y1 OR6K3 OR8K3 OR8U3 OR2Z1 OR51B4 | 1.31e-16 | 343 | 82 | 16 | 32295537 | |
| Pubmed | OR10D3 OR12D3 OR2K2 OR2A7 OR13D1 OR10G2 OR2A4 OR13F1 OR4D1 OR5C1 OR6Y1 OR6K3 OR8K3 OR8U3 OR2Z1 OR51B4 | 1.50e-16 | 346 | 82 | 16 | 14611657 | |
| Pubmed | OR10D3 OR12D3 OR2K2 OR2A7 OR13D1 OR10G2 OR2A4 OR13F1 OR4D1 OR5C1 OR6Y1 OR6K3 OR8K3 OR8U3 OR2Z1 | 2.39e-12 | 541 | 82 | 15 | 14983052 | |
| Pubmed | Regulation of spermatogenesis by testis-specific, cytoplasmic poly(A) polymerase TPAP. | 5.49e-06 | 2 | 82 | 2 | 12471261 | |
| Pubmed | Transcription factor TAFII250 promotes Mdm2-dependent turnover of p53. | 1.64e-05 | 3 | 82 | 2 | 17237821 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 18548200 | ||
| Pubmed | Complex alternative RNA processing generates an unexpected diversity of poly(A) polymerase isoforms. | 1.64e-05 | 3 | 82 | 2 | 8628305 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 27315375 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 20181722 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 9388200 | ||
| Pubmed | A zonal organization of odorant receptor gene expression in the olfactory epithelium. | 3.28e-05 | 4 | 82 | 2 | 7683976 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 8491200 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 31335323 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | CSDE1 TBC1D9B PTPRK STC2 USO1 INF2 POLR2B CSTF3 ERLEC1 IPO11 | 7.44e-05 | 942 | 82 | 10 | 31073040 |
| Pubmed | CARPs enhance p53 turnover by degrading 14-3-3sigma and stabilizing MDM2. | 8.19e-05 | 6 | 82 | 2 | 18382127 | |
| Pubmed | Widespread overexpression of epitope-tagged Mdm4 does not accelerate tumor formation in vivo. | 8.19e-05 | 6 | 82 | 2 | 20855528 | |
| Pubmed | EphB2 and EphB3 forward signalling are required for palate development. | 8.19e-05 | 6 | 82 | 2 | 19032981 | |
| Pubmed | Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum. | 8.19e-05 | 6 | 82 | 2 | 18923023 | |
| Pubmed | 1.14e-04 | 7 | 82 | 2 | 9990854 | ||
| Pubmed | Saturation mutagenesis defines novel mouse models of severe spine deformity. | 1.52e-04 | 8 | 82 | 2 | 34142127 | |
| Pubmed | 1.52e-04 | 8 | 82 | 2 | 7590244 | ||
| Pubmed | 1.78e-04 | 46 | 82 | 3 | 32126975 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CSDE1 PTPN4 INF2 RBBP4 PTPRS SLC16A14 MKLN1 NLRC5 CSTF3 ADGRV1 PDE10A GPT2 | 1.88e-04 | 1489 | 82 | 12 | 28611215 |
| Pubmed | Human Fip1 is a subunit of CPSF that binds to U-rich RNA elements and stimulates poly(A) polymerase. | 1.96e-04 | 9 | 82 | 2 | 14749727 | |
| Pubmed | 1.96e-04 | 9 | 82 | 2 | 28929539 | ||
| Pubmed | Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. | 2.44e-04 | 10 | 82 | 2 | 16413489 | |
| Pubmed | TANGO6 regulates cell proliferation via COPI vesicle-mediated RPB2 nuclear entry. | 2.44e-04 | 10 | 82 | 2 | 38490996 | |
| Pubmed | Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. | 2.44e-04 | 10 | 82 | 2 | 15550623 | |
| Pubmed | Class 3 semaphorins negatively regulate dermal lymphatic network formation. | 2.98e-04 | 11 | 82 | 2 | 26319580 | |
| Pubmed | 2.98e-04 | 11 | 82 | 2 | 26385750 | ||
| Pubmed | Nuclear-localized focal adhesion kinase regulates inflammatory VCAM-1 expression. | 2.98e-04 | 11 | 82 | 2 | 22734001 | |
| Pubmed | 3.57e-04 | 12 | 82 | 2 | 36399562 | ||
| Pubmed | Evolution of odorant receptors expressed in mammalian testes. | 4.21e-04 | 13 | 82 | 2 | 11014824 | |
| Pubmed | 4.91e-04 | 14 | 82 | 2 | 7528109 | ||
| Pubmed | 4.91e-04 | 14 | 82 | 2 | 26320999 | ||
| Pubmed | Inactivation of Mdm2 restores apoptosis proficiency of cooperativity mutant p53 in vivo. | 4.91e-04 | 14 | 82 | 2 | 31749402 | |
| Pubmed | 4.91e-04 | 14 | 82 | 2 | 22665518 | ||
| Pubmed | 5.65e-04 | 15 | 82 | 2 | 10704353 | ||
| Pubmed | Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. | 5.65e-04 | 15 | 82 | 2 | 14992727 | |
| Pubmed | 5.98e-04 | 162 | 82 | 4 | 25826454 | ||
| Pubmed | 6.45e-04 | 16 | 82 | 2 | 8875997 | ||
| Pubmed | 6.45e-04 | 16 | 82 | 2 | 18308476 | ||
| Pubmed | Odorant and vomeronasal receptor genes in two mouse genome assemblies. | 7.26e-04 | 74 | 82 | 3 | 15081110 | |
| Pubmed | Protein tyrosine phosphatases expression during development of mouse superior colliculus. | 7.30e-04 | 17 | 82 | 2 | 19727691 | |
| Pubmed | 7.55e-04 | 75 | 82 | 3 | 25593309 | ||
| Pubmed | 8.20e-04 | 18 | 82 | 2 | 16514057 | ||
| Pubmed | Role for ephrinB2 in postnatal lung alveolar development and elastic matrix integrity. | 8.20e-04 | 18 | 82 | 2 | 18651661 | |
| Pubmed | 8.20e-04 | 18 | 82 | 2 | 15053879 | ||
| Pubmed | Proteomic analysis identifies novel binding partners of BAP1. | 9.11e-04 | 80 | 82 | 3 | 34591877 | |
| Pubmed | PlexinD1 and semaphorin signaling are required in endothelial cells for cardiovascular development. | 9.15e-04 | 19 | 82 | 2 | 15239958 | |
| Pubmed | 9.15e-04 | 19 | 82 | 2 | 15184386 | ||
| Pubmed | 1.12e-03 | 21 | 82 | 2 | 12453419 | ||
| Pubmed | Motor neurons use push-pull signals to direct vascular remodeling critical for their connectivity. | 1.12e-03 | 21 | 82 | 2 | 36240771 | |
| Pubmed | 1.23e-03 | 22 | 82 | 2 | 15162501 | ||
| Pubmed | Distinct fibroblast lineages determine dermal architecture in skin development and repair. | 1.23e-03 | 22 | 82 | 2 | 24336287 | |
| Pubmed | The splicing factor FUBP1 is required for the efficient splicing of oncogene MDM2 pre-mRNA. | 1.47e-03 | 24 | 82 | 2 | 24798327 | |
| Pubmed | 1.47e-03 | 24 | 82 | 2 | 23063659 | ||
| Pubmed | The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function. | 1.59e-03 | 25 | 82 | 2 | 19240132 | |
| Pubmed | 1.59e-03 | 25 | 82 | 2 | 17307970 | ||
| Pubmed | Motor innervation directs the correct development of the mouse sympathetic nervous system. | 1.59e-03 | 25 | 82 | 2 | 39152112 | |
| Pubmed | Expression of members of the putative olfactory receptor gene family in mammalian germ cells. | 1.59e-03 | 25 | 82 | 2 | 1370859 | |
| Pubmed | 1.70e-03 | 730 | 82 | 7 | 34857952 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 1.70e-03 | 363 | 82 | 5 | 14691545 | |
| Pubmed | Extra-embryonic vasculature development is regulated by the transcription factor HAND1. | 1.99e-03 | 28 | 82 | 2 | 15073150 | |
| Pubmed | 2.01e-03 | 377 | 82 | 5 | 25147182 | ||
| Pubmed | CSDE1 TBC1D9B INF2 RBBP4 POLR2B SHMT2 HCFC2 FIGNL1 ERLEC1 IPO11 | 2.05e-03 | 1440 | 82 | 10 | 30833792 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 2.07e-03 | 1201 | 82 | 9 | 35696571 | |
| Pubmed | 2.11e-03 | 560 | 82 | 6 | 35241646 | ||
| Pubmed | Noggin is required for correct guidance of dorsal root ganglion axons. | 2.14e-03 | 29 | 82 | 2 | 12435358 | |
| Pubmed | 2.22e-03 | 109 | 82 | 3 | 12226669 | ||
| GeneFamily | Immunoglobulin like domain containing | 3.51e-04 | 193 | 57 | 5 | 594 | |
| GeneFamily | Olfactory receptors, family 2 | 4.43e-04 | 113 | 57 | 4 | 149 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 1.97e-03 | 21 | 57 | 2 | 813 | |
| GeneFamily | Olfactory receptors, family 13 | 2.37e-03 | 23 | 57 | 2 | 162 | |
| GeneFamily | Phosphodiesterases | 2.58e-03 | 24 | 57 | 2 | 681 | |
| GeneFamily | NLR family | 2.80e-03 | 25 | 57 | 2 | 666 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.73e-06 | 197 | 82 | 6 | f969685dee212f33a6f09e54c0cd1fd24ffef546 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.73e-06 | 197 | 82 | 6 | 1a137af40697137bb9d2b5caf2b1ffda55f04461 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.73e-06 | 197 | 82 | 6 | 96d63a8d00583e2aa0a38412e2ae27e23f399493 | |
| ToppCell | proximal-Endothelial-Bronchial_Vessel_1|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.89e-06 | 200 | 82 | 6 | d034bd210c87b704acf45f50d888497c8737011b | |
| ToppCell | proximal-3-Endothelial-Bronchial_Vessel_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.89e-06 | 200 | 82 | 6 | 0ff4185021ec84b57be13b28495e2f8a4d195eb6 | |
| ToppCell | proximal-Endothelial-Bronchial_Vessel_1-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.89e-06 | 200 | 82 | 6 | e4f6e0b9502eb531f28d605f9dbda6a72a9ed320 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-NK-NK|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.57e-05 | 170 | 82 | 5 | 9a47d03f7eea6299a836a0eb1e7c1252c03f76df | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-NK-NK-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.57e-05 | 170 | 82 | 5 | 4252c0a335762508bd1f8f71c6e78a657d7df125 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-NK|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.57e-05 | 170 | 82 | 5 | 0aa11d8cb44403b6769860dac2d3b05da6fff79d | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 171 | 82 | 5 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 171 | 82 | 5 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | Control-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.66e-05 | 172 | 82 | 5 | c55dce1ed3ed7312394b4e050e1de852a994e130 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-05 | 175 | 82 | 5 | c4088b5f9fa145869cf5dd8bee7680b1c8fada42 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-05 | 175 | 82 | 5 | ca0d3e3a0a271cccdd3881b055fecb626712478d | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.06e-05 | 180 | 82 | 5 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.35e-05 | 185 | 82 | 5 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.60e-05 | 189 | 82 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 2.67e-05 | 190 | 82 | 5 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.74e-05 | 191 | 82 | 5 | 6345c1aa0fd2f9f2154a44f9393bf7c72bb1f44e | |
| ToppCell | (4)_Endothelial_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.88e-05 | 193 | 82 | 5 | ae6ba13d4d9f2a700887cdda2790c32007b29ac8 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.88e-05 | 193 | 82 | 5 | 0f2967afbbf4e538b63f985c0acc2e5d9aab7589 | |
| ToppCell | human_hepatoblastoma-NK.T_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.95e-05 | 194 | 82 | 5 | 997b02a22d7c89a8fd5615bb79a2a8a34fc3fee6 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 3.02e-05 | 195 | 82 | 5 | 120296531bbc8080dcabacbd64733cc1dc34603a | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.02e-05 | 195 | 82 | 5 | fde8e7b38b3631109b95ef111c5f6e3f9878cfbd | |
| ToppCell | control-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.02e-05 | 195 | 82 | 5 | ddbc924b1a08685da0ed0755856178bae99a75b9 | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 3.02e-05 | 195 | 82 | 5 | 6b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-05 | 197 | 82 | 5 | 7caa2c86dc4d50b57a7db8f7278d1588282ad6db | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-05 | 197 | 82 | 5 | 951f18f326967206adbbfc422cce9eea3d2e0854 | |
| ToppCell | (6)_Endothelial-A_(Artery)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.25e-05 | 198 | 82 | 5 | 44f8cd5afa3685dcc8bfea0b15af5e8817e12e2e | |
| ToppCell | distal-1-Endothelial-Bronchial_Vessel_1|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.25e-05 | 198 | 82 | 5 | 5cd81fe1a21c0e1a7f0d5a62ddf8e422b05aedc7 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.33e-05 | 199 | 82 | 5 | e2d5c5cab102e67b0131b02392d81adaedc15965 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.33e-05 | 199 | 82 | 5 | 6fb81388c5045e81c3849a7136bdff3f953f044e | |
| ToppCell | proximal-Endothelial|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.41e-05 | 200 | 82 | 5 | 970dac1b11ae8f4adb26634717064289967b4bde | |
| ToppCell | proximal-3-Endothelial|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.41e-05 | 200 | 82 | 5 | 90c36cfb9632a3bdc9a335b2193f6b08aba35208 | |
| ToppCell | proximal-Endothelial-Bronchial_Vessel_2-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.41e-05 | 200 | 82 | 5 | b6666ade237c39bfde13987685567bad1762baec | |
| ToppCell | proximal-Endothelial-Bronchial_Vessel_2|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.41e-05 | 200 | 82 | 5 | 2ecf7a38799c151ffb09f2677e38a4ffa354c1da | |
| ToppCell | severe-B_intermediate|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.41e-05 | 200 | 82 | 5 | 6d0ac3d00400dd5657ee266f7b885381bf790ce1 | |
| ToppCell | proximal-3-Endothelial-Bronchial_Vessel_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.41e-05 | 200 | 82 | 5 | 038812912bb9f6c1359765614bb9fd138843a306 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.66e-05 | 126 | 82 | 4 | 69b2525b92d1c7c35b21cc701f5fa52a9c1b94bb | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.66e-05 | 126 | 82 | 4 | 6cb89754010d64875e115da6c5805efac7a4a82d | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.49e-04 | 145 | 82 | 4 | afed661aef990edb8e7012ab67ace56443520c9f | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 154 | 82 | 4 | 37765512dfae557b9f6eb30a29463b93682a4404 | |
| ToppCell | facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.28e-04 | 162 | 82 | 4 | 04ccd3d216f8f41afd3434a61264f03d6324db35 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.33e-04 | 163 | 82 | 4 | d6f9b7280c44d120df5a72dfc2ebb26ffbb5752b | |
| ToppCell | PSB-critical-LOC-Lymphoid-PC|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.39e-04 | 164 | 82 | 4 | 3e672124dea2497c5bdf8a315c8cfacfab5780dc | |
| ToppCell | Endothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor | 2.44e-04 | 165 | 82 | 4 | 84e553d699ac56df89a77248f7308b9133e1b683 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.67e-04 | 169 | 82 | 4 | 8caf7996796a2e2716e3855de855c903d6126bf2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-04 | 170 | 82 | 4 | a965e3ee6818790a4a6916824fde64333d9b11b7 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.74e-04 | 170 | 82 | 4 | b04e2f84024baaae9b4ff19bdac8c69afdb92a76 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l48|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.74e-04 | 170 | 82 | 4 | 070d8683d1a5cc7d594ff0453c961a9bf982c2d0 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 2.80e-04 | 171 | 82 | 4 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-04 | 172 | 82 | 4 | 4bdcf1ae2a1cfba0272c54072e37fb7958904321 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.92e-04 | 173 | 82 | 4 | 4968712af1cca8c932abd3323631d7dcaffd4a66 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.92e-04 | 173 | 82 | 4 | ef8d720b99470fe1953661f6e66bc0366266bdb6 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.99e-04 | 174 | 82 | 4 | 110369f6b78de34a6d934b5b47cecd023347bc80 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.05e-04 | 175 | 82 | 4 | 2e54961846c65b185d9bd6e305dd81205579d890 | |
| ToppCell | IIF-Lymphocyte-B-B_intermediate|IIF / Disease, Lineage and Cell Type | 3.05e-04 | 175 | 82 | 4 | 327f8ee3669c3fc5ba50abc3b4f3e068637fd8d8 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.05e-04 | 175 | 82 | 4 | efa6a05f7417d46141b6e635f258c126b7a03aa1 | |
| ToppCell | Endothelial-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 3.12e-04 | 176 | 82 | 4 | b288116a4588a1f9db9d49af92cea118937c9201 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.12e-04 | 176 | 82 | 4 | 96779273b94345250cf53ba671203345b43d9e00 | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.19e-04 | 177 | 82 | 4 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 3.19e-04 | 177 | 82 | 4 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.19e-04 | 177 | 82 | 4 | c1f838e425ebb04482829b1957e3c1347127e6de | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.33e-04 | 179 | 82 | 4 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.33e-04 | 179 | 82 | 4 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 3.40e-04 | 180 | 82 | 4 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 3.40e-04 | 180 | 82 | 4 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-04 | 180 | 82 | 4 | 41e8155cc7b3dac9d496e4077845ca6af1591a5c | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 3.47e-04 | 181 | 82 | 4 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | facs-BAT-Fat-18m|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-04 | 182 | 82 | 4 | efc335f4e566533cfbcd17262bd94ae64fa2e117 | |
| ToppCell | RA-17._Lymphocyte|RA / Chamber and Cluster_Paper | 3.54e-04 | 182 | 82 | 4 | 257a7847917b6ea1d60608183d90300bfd028758 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.62e-04 | 183 | 82 | 4 | 52af3c943116073c8ddd207b664342960b88929b | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.62e-04 | 183 | 82 | 4 | 956ff95aef9c5521b6a3ba7ac6df0aad242c1c35 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 183 | 82 | 4 | 769a022fe8568ec49e66f792cc5777e713a7571c | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.62e-04 | 183 | 82 | 4 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.62e-04 | 183 | 82 | 4 | dbc7ec66da5930c2bf4e0405937b054e04c22a34 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.62e-04 | 183 | 82 | 4 | a644258ba90acc62d571623e429d72ffc4b69203 | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.62e-04 | 183 | 82 | 4 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-04 | 183 | 82 | 4 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 183 | 82 | 4 | aac0695fafa59cabd920ee18b1139d3e00d898e8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-04 | 184 | 82 | 4 | ae0a77e3e520a246b17776bb19503519636b02ee | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 184 | 82 | 4 | b998803180322a5ea2b567928dea531c26816c3c | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 184 | 82 | 4 | f17d713af4a97dff4eeeab24c405677ef2ffcf84 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.69e-04 | 184 | 82 | 4 | e5756afa3181186f9b65552b8df5359ef4024bee | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.69e-04 | 184 | 82 | 4 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 3.77e-04 | 185 | 82 | 4 | 4abe04198ab5047c211f8d09cdb9650fa52a3cd6 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.77e-04 | 185 | 82 | 4 | 0e0f043ad6d2a62cd47ce39911ad81feab4a4d7e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.77e-04 | 185 | 82 | 4 | a987dbf6adf533c5f8a0a8a465a6c8e67e0ffcc8 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-04 | 185 | 82 | 4 | 5527fa9d2e0b2f3607602e18ba94de4e9bbc6824 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.77e-04 | 185 | 82 | 4 | 89b85ce8026dc80c1bd9f76dfe16401c173b7946 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.77e-04 | 185 | 82 | 4 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor | 3.77e-04 | 185 | 82 | 4 | 07f9f38f0739d7c830641723a38385550ac1ac92 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-CD56_bright_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.77e-04 | 185 | 82 | 4 | 593eceb3dfcc662c892a840ba29ab687c6886c01 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.77e-04 | 185 | 82 | 4 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.85e-04 | 186 | 82 | 4 | f0b78c7ee20279970ea8961bf59acb5262f2dce5 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.85e-04 | 186 | 82 | 4 | dae6a98963c78bf7518ebab8dc02f173c3b0f7f7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.85e-04 | 186 | 82 | 4 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|COPD / Disease state, Lineage and Cell class | 3.85e-04 | 186 | 82 | 4 | 23c7d0e8372a71546d687278b985f761d282f92f | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.85e-04 | 186 | 82 | 4 | e9d12f2fcd346fc8d00f7178324ea5997628df8a | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.85e-04 | 186 | 82 | 4 | 080e56113b89138277a2bd2eabddfa6cd1a18b61 | |
| Disease | brain connectivity measurement | 5.09e-04 | 400 | 74 | 6 | EFO_0005210 | |
| Disease | thalamus volume | 1.29e-03 | 85 | 74 | 3 | EFO_0006935 | |
| Disease | Malignant neoplasm of breast | 1.44e-03 | 1074 | 74 | 9 | C0006142 | |
| Disease | peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease | 1.65e-03 | 24 | 74 | 2 | EFO_0003948, EFO_0009923, MONDO_0004247 | |
| Disease | upper face morphology measurement | 1.89e-03 | 97 | 74 | 3 | EFO_0010949 | |
| Disease | executive function measurement | 2.57e-03 | 376 | 74 | 5 | EFO_0009332 | |
| Disease | diastolic blood pressure, alcohol drinking | 3.29e-03 | 118 | 74 | 3 | EFO_0004329, EFO_0006336 | |
| Disease | age at first birth measurement | 3.45e-03 | 120 | 74 | 3 | EFO_0009101 | |
| Disease | high grade glioma (is_marker_for) | 5.01e-03 | 42 | 74 | 2 | DOID:3070 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ITFLRQVMALCTYPN | 106 | Q8TD30 | |
| LKQNRPRSSTVMYIC | 201 | Q96DZ1 | |
| MGRYRCTVENPVTQL | 291 | A8MTB9 | |
| TVARFQSPNIRMCFI | 101 | A6NF34 | |
| QMVYRVQEPLERSSC | 2356 | Q8WXG9 | |
| MAYNITPLRRATVEC | 666 | O75534 | |
| LRLYCNTSVPAMRIA | 296 | Q86WK7 | |
| ISSQYVIRMQPTNRC | 206 | Q8NBA8 | |
| PCMEVIRYAVQVLLN | 3311 | Q8IZT6 | |
| VNEMCPNITRIYNIG | 331 | Q8N436 | |
| VNSCMGRVRRIYPQL | 851 | Q68CQ1 | |
| RAMMIQTPSQYRFVC | 891 | P29074 | |
| QACTPMFREYSLQVL | 341 | P34897 | |
| AMLVARTCQLYPNAV | 251 | Q9NRJ5 | |
| EYSRQCSMVGQPVRR | 276 | Q6W4X9 | |
| LTTMAIDRYVAICNP | 131 | Q8NGY3 | |
| LRYQMIMTPRLCAQL | 146 | Q8NGY3 | |
| MVRALFAVARCQQPA | 481 | Q6PIW4 | |
| IQDNPSQLVFMRIYC | 721 | Q9Y5Z7 | |
| SAVCMLVRPRALYNM | 216 | Q9HB89 | |
| LVRPRALYNMVVQTT | 221 | Q9HB89 | |
| VQADRALYLMCTVPA | 316 | Q7RTR2 | |
| CVIERVNMQIRPYVG | 586 | Q9UI26 | |
| PLRYNCILTNSRVMN | 126 | Q9Y5P0 | |
| VCQPLQYPVLMRRQV | 126 | Q8NG97 | |
| GYTTRNILCMPIVSR | 361 | Q9Y233 | |
| NRPLTCIMYAIFQER | 361 | Q07343 | |
| QIVVCEMLSQPRISY | 401 | P16284 | |
| TAVRRVYQRGCVNPM | 166 | Q12996 | |
| AMNPIRTYQVCNVRE | 71 | P54753 | |
| VDCLTLGQYMQPTRR | 301 | O43766 | |
| PQQMIISRYLLSVCG | 601 | A8MRT5 | |
| VNCSVVAAVRTMYPI | 261 | P43657 | |
| TVAPALQRCQTYMDI | 151 | Q9UKX5 | |
| TAMEYCQRVLRKPAQ | 801 | Q9UKX5 | |
| AVVDIAYACNTVPRM | 66 | Q96R45 | |
| AYACNTVPRMLVNLL | 71 | Q96R45 | |
| RNPLLYTTAMSQRLC | 131 | Q8NGR4 | |
| LQQIPTERYGIDCIM | 306 | Q8IY84 | |
| GNTVVCIIVYQRPAM | 51 | Q9Y5Y3 | |
| CIIVYQRPAMRSAIN | 56 | Q9Y5Y3 | |
| ELCIRLLQMPSVVNY | 36 | Q27J81 | |
| MRGRALRYINITNCV | 391 | Q7Z2Q7 | |
| ARVAVTCPTVRMLQA | 791 | Q86WI3 | |
| EVNRARYMPQNPCII | 126 | Q09028 | |
| LVNIMPYESTRVCLQ | 1711 | Q13332 | |
| AVVDIAYACNTVPRM | 66 | O95047 | |
| AYACNTVPRMLVNLL | 71 | O95047 | |
| FVAICNPLRYTVIMN | 121 | Q9UGF7 | |
| NPLRYTVIMNPQVCI | 126 | Q9UGF7 | |
| MLVARTCQLYPNAIA | 251 | P51003 | |
| IMLQYCFPRLDINVS | 296 | P49642 | |
| FRPIIVALMARACNI | 136 | Q5T2R2 | |
| NGIIMYTRANPCIIL | 3871 | Q8TDW7 | |
| NMLLYCVPRVIQVGA | 346 | Q7Z6J4 | |
| APIRSVDVYNVMCNV | 381 | Q6UWR7 | |
| VPARYCNHMIIQRVI | 41 | Q5GAN4 | |
| RYVTIMNTQLCVGLV | 131 | Q15615 | |
| RICNLTRPQEGYLMV | 1316 | Q15262 | |
| RYTVIMNPRICVALA | 131 | Q8NH80 | |
| RYPVLMNGRLCTVLV | 136 | Q8NGC3 | |
| VAICNPLRYSIIMNG | 156 | Q8NGV5 | |
| RYPVIMNRRTCVQIA | 131 | Q8NGS4 | |
| ICNPLRYSIIMNRCV | 126 | Q8NGT1 | |
| VSNAMCRELPQSIVY | 381 | Q12805 | |
| SMVNERQPFVLRCAV | 371 | O60763 | |
| MCTYVNRGRRAQATP | 141 | Q13275 | |
| MRTPTNCYLVSLAVA | 56 | P34981 | |
| PCRNFQVLVAYSMLQ | 266 | Q8IYX1 | |
| CLVRVYMVRAINLQP | 1486 | A0AVI2 | |
| SVRCRLYNTPMQAIS | 1616 | Q6T4R5 | |
| QPCIRIIEQSRRKYM | 491 | Q7RTX9 | |
| MCIDIQRRQIYTLGR | 331 | Q9UL63 | |
| SRRYQQTMGSLQPLC | 121 | P21675 | |
| PVCRQPIQMIVLTYF | 476 | Q00987 | |
| RNKTQISLVRMPYAC | 1141 | P30876 | |
| EYSANCLRMVATQPI | 261 | Q8TBK2 | |
| MSRRVCIQLVAVPYI | 136 | Q8NH85 | |
| MSRRVCQVLVAIPYL | 136 | Q8NH51 | |
| RYPVIMTNQLCGTLA | 136 | Q8NGX8 | |
| ISVVYLRCPEMVENR | 71 | Q13278 | |
| RNPTIGYCQAMNIVT | 586 | Q66K14 | |
| QLQPMVTQLRYESFC | 156 | Q96LW9 | |
| TPQTCMLRIYIAFQD | 16 | Q9H081 | |
| KRMSECPICRQYVVR | 351 | Q969K3 | |
| PAIREMVSQLQRECY | 126 | O76061 | |
| RNLVPVTRVMYCVLS | 86 | Q13342 | |
| TNYPRSVAVLTECMR | 206 | Q9ULL1 | |
| VTQAMEYVRSGCRNP | 486 | O94900 | |
| RLAQAQSMCLPIYRE | 1116 | Q14957 |